Early Clinical Development of CIT-013, a First in Class NETosis Inhibitor, in a Randomized Phase I Dose Escalation Study in Healthy Volunteers Demonstrating Potent Inhibition of LPS Induced Neutrophil Extracellular Trap Formation

CIT-013 - Citryll

Leonie Middelink1; Renato Chirivi2; Helmuth van Es2; Eric Meldrum2; Peter van Zandvoort2; Tirza Bruurmijn2; Matthijs Moerland3; Patrick Round2

Oct 25, 2023